GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 208 filers reported holding GENMAB A/S in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,849 | -12.0% | 9,182 | -5.2% | 0.02% | -4.5% |
| Q2 2023 | $368,127 | +12.9% | 9,685 | +12.2% | 0.02% | +4.8% |
| Q1 2023 | $325,944 | +16.7% | 8,632 | +31.0% | 0.02% | 0.0% |
| Q4 2022 | $279,242 | -9.0% | 6,589 | -30.9% | 0.02% | -30.0% |
| Q3 2022 | $307,000 | -1.3% | 9,542 | -0.3% | 0.03% | +3.4% |
| Q2 2022 | $311,000 | -22.1% | 9,570 | -13.3% | 0.03% | -6.5% |
| Q1 2022 | $399,000 | +6.1% | 11,036 | +28.4% | 0.03% | -20.5% |
| Q3 2021 | $376,000 | – | 8,595 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |